A real world study analysing risk of end-stage renal disease among hepatitis C patients with chronic kidney disease treated with and without sofosbuvir
Latest Information Update: 16 Oct 2020
At a glance
- Drugs Sofosbuvir (Primary) ; Antivirals
- Indications Hepatitis C
- Focus Adverse reactions
- 16 Oct 2020 New trial record
- 29 Aug 2020 Results presented at The International Liver Congress 2020